[HTML][HTML] The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell …
X Zhang, J Chen, MZ Han, H Huang, E Jiang… - Journal of hematology & …, 2021 - Springer
The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH)
on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem …
on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem …
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
Y Wang, QF Liu, LP Xu, KY Liu… - Blood, The Journal …, 2015 - ashpublications.org
The effects of HLA-identical sibling donor (ISD) hematopoietic stem cell transplantation
(HSCT) on adults with intermediate-or high-risk acute myeloid leukemia (AML) in the first …
(HSCT) on adults with intermediate-or high-risk acute myeloid leukemia (AML) in the first …
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable …
DP Lu, L Dong, T Wu, XJ Huang, MJ Zhang, W Han… - Blood, 2006 - ashpublications.org
The outcomes of 293 patients with leukemia undergoing HLA-identical sibling (n= 158) or
related HLA-mismatched (n= 135) hematopoietic cell transplantation (HCT) performed …
related HLA-mismatched (n= 135) hematopoietic cell transplantation (HCT) performed …
Who is the best donor for a related HLA haplotype-mismatched transplant?
Y Wang, YJ Chang, LP Xu, KY Liu… - Blood, The Journal …, 2014 - ashpublications.org
The best donor for a related donor for a human leukocyte antigen (HLA) haplotype-
mismatched transplant for hematological neoplasms is controversial. We studied outcomes …
mismatched transplant for hematological neoplasms is controversial. We studied outcomes …
MRD-directed risk stratification treatment may improve outcomes of t (8; 21) AML in the first complete remission: results from the AML05 multicenter trial
HH Zhu, XH Zhang, YZ Qin, DH Liu… - Blood, The Journal …, 2013 - ashpublications.org
We aimed to improve the outcome of t (8; 21) acute myeloid leukemia (AML) in the first
complete remission (CR1) by applying risk-directed therapy based on minimal residual …
complete remission (CR1) by applying risk-directed therapy based on minimal residual …
[HTML][HTML] Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation
XJ Huang, DH Liu, KY Liu, LP Xu, H Chen… - Biology of blood and …, 2009 - Elsevier
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains one of the best
therapeutic options to cure acute leukemia (AL). However, many patients have no human …
therapeutic options to cure acute leukemia (AL). However, many patients have no human …
Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell …
CH Yan, DH Liu, KY Liu, LP Xu, YR Liu… - Blood, The Journal …, 2012 - ashpublications.org
We studied the impact of risk stratification–directed interventions for minimal residual
disease (MRD) on relapse and disease-free survival (DFS) prospectively in 814 subjects …
disease (MRD) on relapse and disease-free survival (DFS) prospectively in 814 subjects …
Long‐term follow‐up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at …
Y Wang, DH Liu, KY Liu, LP Xu, XH Zhang, W Han… - Cancer, 2013 - Wiley Online Library
BACKGROUND: Many patients who require allogeneic hematopoietic stem cell
transplantation (allo‐HSCT) lack a human leukocyte antigen (HLA)‐matched donor …
transplantation (allo‐HSCT) lack a human leukocyte antigen (HLA)‐matched donor …
[HTML][HTML] Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
LP Xu, S Jin, SQ Wang, LH Xia, H Bai, SJ Gao… - Journal of hematology & …, 2017 - Springer
Background Haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) is
an alternative treatment method for severe aplastic anemia (SAA) patients lacking suitable …
an alternative treatment method for severe aplastic anemia (SAA) patients lacking suitable …
[HTML][HTML] Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow …
YJ Chang, XY Zhao, LP Xu, XH Zhang, Y Wang… - Journal of hematology & …, 2015 - Springer
Background Small studies suggest an association of donor-specific anti-human leukocyte
antigen (HLA) antibodies (DSAs) with primary graft failure (GF) following haploidentical stem …
antigen (HLA) antibodies (DSAs) with primary graft failure (GF) following haploidentical stem …